PCAT1 Supports Partial AR-V7 Function and Promotes Enzalutamide Resistance in Prostate Cancer
Open Access
- 1 July 2026
- journal article
- research article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-11
Abstract
Background: Enzalutamide resistance (Enz-R) remains a major clinical challenge in advanced prostate cancer (PCa). Here, we identified resistance-associated long non-coding RNA (lncRNA) PCAT1 and investigated its functional relevance in Enz-R PCa. Methods: Public transcriptomic datasets, bioinformatic analyses, RNA immunoprecipitation (RIP), ChIP-qPCR, and in vitro and in vivo functional assays were used to evaluate the expression, function, and potential mechanism of PCAT1 in Enz-R PCa models. Results: PCAT1 was upregulated in Enz-R PCa models and was associated with adverse clinical features. PCAT1 knockdown inhibited the growth of C4-2 Enz-R cells and 22Rv1 cells and suppressed tumor growth in vivo. Mechanistically, PCAT1 was associated with AR/AR-V7 and supported selected AR-V7-associated downstream outputs without markedly altering AR-V7 protein expression. AR-V7 ChIP-qPCR further suggested that PCAT1 knockdown reduced AR-V7 enrichment at selected regulatory regions, including the KLK3 and PMEPA1 enhancers. In addition, high-dose androgen treatment reduced PCAT1 and AR-V7 expression in our experimental model. Conclusion: PCAT1 contributes to Enz-R PCa growth and may support selected AR-V7-associated transcriptional outputs. PCAT1 may represent a potential therapeutic vulnerability, and the relationship between high-dose androgen treatment, PCAT1 suppression, and AR-V7 signaling warrants further investigation.Keywords
This publication has 32 references indexed in Scilit:
- Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease ProgressionEuropean Urology, 2018
- Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancerNature Genetics, 2016
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancerNature Medicine, 2016
- The Molecular Taxonomy of Primary Prostate CancerCell, 2015
- catRAPID signature: identification of ribonucleoproteins and RNA-binding regionsBioinformatics, 2015
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate CancerNew England Journal of Medicine, 2014
- Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cellsThe International Journal of Biochemistry & Cell Biology, 2014
- The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expressionGenome Research, 2012
- Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progressionNature Biotechnology, 2011
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variantJournal of Clinical Investigation, 2010